Cuorips Inc. Share Price

Equities

4894

JP3266030000

Pharmaceuticals

Market Closed - Japan Exchange 11:30:00 14/06/2024 am IST 5-day change 1st Jan Change
8,550 JPY +11.91% Intraday chart for Cuorips Inc. +66.67% +268.38%

Financials

Sales 2022 13 2.05K 1.09K Sales 2023 38 5.98K 3.17K Capitalization 387M 60.95B 32.34B
Net income 2022 -375M -59.03B -31.32B Net income 2023 -452M -71.15B -37.75B EV / Sales 2022 * -
Net cash position 2022 * - 0 0 Net cash position 2023 * - 0 0 EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees 43
Yield 2022 *
-
Yield 2023 *
-
Free-Float 71.16%
More Fundamentals * Assessed data
Dynamic Chart
1 day+11.91%
1 week+66.67%
Current month+69.98%
1 month+150.37%
3 months+144.64%
6 months+367.21%
Current year+268.38%
More quotes
1 week
5 550.00
Extreme 5550
9 020.00
1 month
2 780.00
Extreme 2780
9 020.00
Current year
1 952.00
Extreme 1952
9 020.00
1 year
1 287.00
Extreme 1287
9 020.00
3 years
1 287.00
Extreme 1287
9 020.00
5 years
1 287.00
Extreme 1287
9 020.00
10 years
1 287.00
Extreme 1287
9 020.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 01/20/01
Chief Tech/Sci/R&D Officer 68 01/21/01
Chief Administrative Officer 68 01/17/01
Members of the board TitleAgeSince
Director/Board Member 65 01/20/01
Chief Executive Officer 65 01/20/01
Chief Administrative Officer 68 01/17/01
More insiders
Cuorips Inc is a Japan-based company mainly engaged in the development and commercialization of regenerative medical products and contract development and manufacturing organization (CDMO) business. The main product of the Company is human iPS cell-derived cardiomyocyte sheets. The Company provides regenerative medical products for the heart and other areas through in-house research, joint research with universities and other research institutions and major pharmaceutical companies. The Company operates CDMO business using CLiC-1, a commercial cell culture and processing facility with an integrated laboratory based on the Company's original design concept.
More about the company

Annual profits - Rate of surprise